Altafluor Benox

Active Ingredient(s): Benoxinate Hydrochloride + Fluorescein Sodium
FDA Approved: * December 14, 2017
Pharm Company: * ALTAIRE PHARMS INC
Category: Anesthetic

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Altafluor Benox Overview

Oxybuprocaine (INN), also known as benoxinate or BNX, is an ester-type local anesthetic, which is used especially in ophthalmology and otolaryngology. Oxybuprocaine is sold by Novartis under the brand names Novesine or Novesin. Safety for use in pregnancy and lactation has not been established. Contents 1 Uses 2 Pharmacokinetics 3 Adverse effects 4 Interactions 5 See also 6 References Uses In ophthalmology in order to numb the surface of the eye (the outermost layers of the corne...

Read more Altafluor Benox Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Oxybuprocaine

Recent Altafluor Benox Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Benoxinate Hydrochloride + Fluorescein Sodium
  • Ointment: 0.4% + 0.25%
  • Solution: 0.4% + 0.25%
  • Solution/drops: 0.4% + 0.25%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Drugs with one or more similar ingredients: (3 results)





Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. Site content is Copyright © 2005-2018 MedsChat.com and is protected under U.S. and International Copyright laws. All Rights Reserved. This page was last updated on 23 February 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® and The People's Medicine Community® are registered trademarks of Limelight Innovations L.L.C.